Eric Steen is the founder of Lygos. Lygos has raised $230M in total funding. Backed by In-Q-Tel, First Round Capital, IA Ventures.
Eric Steen is the Co-founder and CEO of Lygos, a biotechnology company focused on developing renewable chemicals through engineered biology. He holds both a Ph.D. in Bioengineering and a BS in Management of Technology from UC Berkeley. Steen leads Lygos in areas of hardtech, sustainability, and biotech, with an emphasis on scaling operations and portfolio value.
Full founder directory · Investor directory · Company funding database · Fundraising library